A Greek chemistry student arrived in America with little English and a dictionary. His journey through Harvard and three pharmaceutical giants now meets its most curious problem: teaching machines to read the chemistry that living things have spent eons writing.

An electrical engineer wandered into biology and never accepted its departmental borders. At Enveda, Joe Rokicki turned that restlessness into a method for building the tools that let nature's chemistry speak.

The founder of Enveda turned an old question - what has nature already invented? - into a new kind of drug-discovery company, built across Boulder and Hyderabad and designed to keep learning around the clock.

After learning to scale systems at Google, the Pragma Bio co-founder turned toward a harder map: the mostly unread chemistry made by living systems. His next chapter at Enveda puts that long-running idea inside a larger machine for translating nature into new molecules.